Apostolos Anastasios, Gerakaris Andreas, Tsoni Evropi, Pappelis Konstantinos, Vasilagkos Georgios, Bousoula Elena, Moulias Athanasios, Konstantinou Konstantinos, Dimitriadis Kyriakos, Karamasis Grigoris V, Aminian Adel, Toutouzas Konstantinos, Davlouros Periklis, Tsigkas Grigorios
Department of Cardiology, University Hospital of Patras, 26504 Patras, Greece.
First Department of Cardiology, Medical School, National and Kapodistrian University of Athens, Hippokration Hospital, 11527 Athens, Greece.
Rev Cardiovasc Med. 2023 Jan 12;24(1):26. doi: 10.31083/j.rcm2401026. eCollection 2023 Jan.
Left Main Coronary Artery (LMCA) disease is considered a standout manifestation of coronary artery disease (CAD), because it is accompanied by the highest mortality. Increased mortality is expected, because LMCA is responsible for supplying up to 80% of total blood flow to the left ventricle in a right-dominant coronary system. Due to the significant progress of biomedical technology, the modern drug-eluting stents have remarkably improved the prognosis of patients with LMCA disease treated invasively. In fact, numerous randomized trials provided similar results in one- and five-year survival of patients treated with percutaneous coronary interventions (PCI) -guided with optimal imaging and coronary artery bypass surgery (CABG). However, interventional treatment requires optimal imaging of the LMCA disease, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT). The aim of this manuscript is to review the main pathophysiological characteristics, to present the imaging techniques of LMCA, and, last, to discuss the future directions in the depiction of LMCA disease.
左主干冠状动脉(LMCA)疾病被认为是冠状动脉疾病(CAD)的一种突出表现,因为它伴随着最高的死亡率。预计死亡率会增加,因为在右优势冠状动脉系统中,LMCA负责为左心室提供高达80%的总血流量。由于生物医学技术的显著进步,现代药物洗脱支架显著改善了接受侵入性治疗的LMCA疾病患者的预后。事实上,众多随机试验在接受经皮冠状动脉介入治疗(PCI)(在最佳成像引导下)和冠状动脉旁路移植术(CABG)治疗的患者的1年和5年生存率方面提供了相似的结果。然而,介入治疗需要对LMCA疾病进行最佳成像,如血管内超声(IVUS)和光学相干断层扫描(OCT)。本手稿的目的是回顾主要的病理生理特征,介绍LMCA的成像技术,最后讨论LMCA疾病描述的未来方向。